Showing 21,041 - 21,060 results of 30,146 for search '(( significant ((largest decrease) OR (year increase)) ) OR ( significant decrease decrease ))', query time: 0.69s Refine Results
  1. 21041

    Table 2_Arginine supplementation improves lactate dehydrogenase levels in steady-state sickle cell patients: preliminary findings from Kinshasa, the Democratic Republic of Congo.do... by Ange C. M. Ngonde (20311575)

    Published 2024
    “…</p>Results<p>The cohort had a median age of 12 years, ranging from 2 to 43 years. Throughout all three phases of the study, lactate dehydrogenase (LDH) levels were consistently above the established normal ranges, with elevations of 216.7%, 220.3% and 176.6% above the normative values for baseline, Phase 1 (HU) and Phase 2 (HU + Arg), respectively. …”
  2. 21042

    Table 3_Arginine supplementation improves lactate dehydrogenase levels in steady-state sickle cell patients: preliminary findings from Kinshasa, the Democratic Republic of Congo.do... by Ange C. M. Ngonde (20311575)

    Published 2024
    “…</p>Results<p>The cohort had a median age of 12 years, ranging from 2 to 43 years. Throughout all three phases of the study, lactate dehydrogenase (LDH) levels were consistently above the established normal ranges, with elevations of 216.7%, 220.3% and 176.6% above the normative values for baseline, Phase 1 (HU) and Phase 2 (HU + Arg), respectively. …”
  3. 21043

    Table 6_Arginine supplementation improves lactate dehydrogenase levels in steady-state sickle cell patients: preliminary findings from Kinshasa, the Democratic Republic of Congo.do... by Ange C. M. Ngonde (20311575)

    Published 2024
    “…</p>Results<p>The cohort had a median age of 12 years, ranging from 2 to 43 years. Throughout all three phases of the study, lactate dehydrogenase (LDH) levels were consistently above the established normal ranges, with elevations of 216.7%, 220.3% and 176.6% above the normative values for baseline, Phase 1 (HU) and Phase 2 (HU + Arg), respectively. …”
  4. 21044

    Data Set for Barriers in Cervical cancer Screening by ADWOA BEMAH BOAMAH MENSAH (4924453)

    Published 2024
    “…However, there are significant geographic disparities in access to screening. …”
  5. 21045

    Region-scale decline in streamflow across New South Wales catchments by Danlu Guo (12549226)

    Published 2025
    “…Nearly all (104) catchments have decreasing trends in annual flow, with 32 of these being statistically significant, indicating an overall drying pattern. …”
  6. 21046

    <b>Species removal dampens the scale dependency of ecological determinism and stochasticity in coastal communities.</b> by Nelson Valdivia (600515)

    Published 2025
    “…The effect of foundation species removal on NST was strongest in smaller sessile communities and diminished as spatial extent increased, while mobile communities showed no significant response to the disturbance. …”
  7. 21047

    Data Sheet 1_Changes in cortical brain activity after active break in preschoolers: MOVI-HIIT study.pdf by María Valdivieso-González (22225891)

    Published 2025
    “…</p>Results<p>EEG data revealing significant increases in Theta, Alpha1, and Alpha2 bands, suggesting enhanced relaxation, attentiveness, and readiness to learn. …”
  8. 21048

    Plant species loss reduces rare soil microbes through diversity effect amplified by multitrophic interactions by Jie Li (14726914)

    Published 2025
    “…We found that the removal of rare forbs, rather than dominant species and common plants, significantly decreased the richness of soil bacteria and fungi by decreasing rare microbial taxa in later years. …”
  9. 21049

    Data Sheet 3_Proteomic and transcriptomic analyses identify apo-transcobalamin-II as a biomarker of overall survival in osteosarcoma.xlsx by Ryan A. Lacinski (19866948)

    Published 2024
    “…Following identification of differentially expressed proteins (DEPs) between 2-year deceased and survivor cohorts, publicly available databases including Survival Genie, TIGER, and KM Plotter Immunotherapy, among others, were utilized to investigate the significance of our proteomic findings.…”
  10. 21050

    Data Sheet 1_Proteomic and transcriptomic analyses identify apo-transcobalamin-II as a biomarker of overall survival in osteosarcoma.docx by Ryan A. Lacinski (19866948)

    Published 2024
    “…Following identification of differentially expressed proteins (DEPs) between 2-year deceased and survivor cohorts, publicly available databases including Survival Genie, TIGER, and KM Plotter Immunotherapy, among others, were utilized to investigate the significance of our proteomic findings.…”
  11. 21051

    Data Sheet 2_Proteomic and transcriptomic analyses identify apo-transcobalamin-II as a biomarker of overall survival in osteosarcoma.xlsx by Ryan A. Lacinski (19866948)

    Published 2024
    “…Following identification of differentially expressed proteins (DEPs) between 2-year deceased and survivor cohorts, publicly available databases including Survival Genie, TIGER, and KM Plotter Immunotherapy, among others, were utilized to investigate the significance of our proteomic findings.…”
  12. 21052

    Data Sheet 4_Proteomic and transcriptomic analyses identify apo-transcobalamin-II as a biomarker of overall survival in osteosarcoma.xlsx by Ryan A. Lacinski (19866948)

    Published 2024
    “…Following identification of differentially expressed proteins (DEPs) between 2-year deceased and survivor cohorts, publicly available databases including Survival Genie, TIGER, and KM Plotter Immunotherapy, among others, were utilized to investigate the significance of our proteomic findings.…”
  13. 21053

    Image 4_Prediction of major adverse cardiovascular events following ST-segment elevation myocardial infarction using cardiac obesity marker—epicardial adipose tissue mass index: a... by Zeyan Liu (3748747)

    Published 2025
    “…Background<p>Although reperfusion therapy has led to improvements in the acute phase of ST-segment elevation myocardial infarction (STEMI), the incidence of major adverse cardiovascular events (MACE) following STEMI has not significantly decreased. The accumulation of epicardial adipose tissue (EAT) may be associated with poorer STEMI prognosis and could serve as a potential prognostic marker. …”
  14. 21054

    Image 2_Prediction of major adverse cardiovascular events following ST-segment elevation myocardial infarction using cardiac obesity marker—epicardial adipose tissue mass index: a... by Zeyan Liu (3748747)

    Published 2025
    “…Background<p>Although reperfusion therapy has led to improvements in the acute phase of ST-segment elevation myocardial infarction (STEMI), the incidence of major adverse cardiovascular events (MACE) following STEMI has not significantly decreased. The accumulation of epicardial adipose tissue (EAT) may be associated with poorer STEMI prognosis and could serve as a potential prognostic marker. …”
  15. 21055

    Image 5_Prediction of major adverse cardiovascular events following ST-segment elevation myocardial infarction using cardiac obesity marker—epicardial adipose tissue mass index: a... by Zeyan Liu (3748747)

    Published 2025
    “…Background<p>Although reperfusion therapy has led to improvements in the acute phase of ST-segment elevation myocardial infarction (STEMI), the incidence of major adverse cardiovascular events (MACE) following STEMI has not significantly decreased. The accumulation of epicardial adipose tissue (EAT) may be associated with poorer STEMI prognosis and could serve as a potential prognostic marker. …”
  16. 21056

    Image 1_Prediction of major adverse cardiovascular events following ST-segment elevation myocardial infarction using cardiac obesity marker—epicardial adipose tissue mass index: a... by Zeyan Liu (3748747)

    Published 2025
    “…Background<p>Although reperfusion therapy has led to improvements in the acute phase of ST-segment elevation myocardial infarction (STEMI), the incidence of major adverse cardiovascular events (MACE) following STEMI has not significantly decreased. The accumulation of epicardial adipose tissue (EAT) may be associated with poorer STEMI prognosis and could serve as a potential prognostic marker. …”
  17. 21057

    Image 3_Prediction of major adverse cardiovascular events following ST-segment elevation myocardial infarction using cardiac obesity marker—epicardial adipose tissue mass index: a... by Zeyan Liu (3748747)

    Published 2025
    “…Background<p>Although reperfusion therapy has led to improvements in the acute phase of ST-segment elevation myocardial infarction (STEMI), the incidence of major adverse cardiovascular events (MACE) following STEMI has not significantly decreased. The accumulation of epicardial adipose tissue (EAT) may be associated with poorer STEMI prognosis and could serve as a potential prognostic marker. …”
  18. 21058

    CARE-checklist JOSPT.docx by Hrutuja Karekar (19749936)

    Published 2024
    “…Following the intervention, the patient's range of motion, muscle strength, and pain levels all were significantly improved.</p><p dir="ltr">Conclusion: An 18-year-old with sickle cell disease was provided with physical therapy after hip replacement that is specifically customized to meet their needs and stage of recovery. …”
  19. 21059

    Data Sheet 1_Bibliometric analysis of cognitive dysfunction after traumatic brain injury.docx by Jihua Hu (3571679)

    Published 2025
    “…</p>Results<p>The publication volume of articles was increasing year by year, with articles published in 537 journals. …”
  20. 21060

    Table 1_Complication development trajectories for patients with type 2 diabetes mellitus: evidence from a five-million retrospective cohort study.docx by Haoqing Tang (12088396)

    Published 2025
    “…</p>Results<p>The prevalence of T2DM-related complications increased from 30.4% in 2013 to 53.1% in 2023. The median time from diagnosis to the first complication was 7.5 years. …”